Physician
Omni Womens Health Medical Group INC
Omni Womens Health Medical Group INC was paid $4.43M by Medicaid between Jan 2018 and Dec 2024, across 81 billing codes. Its largest line is Z1034, — 22% of everything it billed.
33Billing provider infoOMNI WOMENS HEALTH MEDICAL GROUP INC
FRESNO, CA 93726
FRESNO, CA 93726
33aNPI1396721197assigned 12/22/2005
33bProvider typeGynecology Physician
28Total paid$4.43M
24GClaims503,818
24DCodes billed81
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Gynecology Physician providers in California
Rank by total paid#2 of 47
Median peer was paid$37K
This provider vs. median121×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 89,062 | $1.27M | |
| 2019 | 70,324 | $539K | |
| 2020 | 69,022 | $544K | |
| 2021 | 73,211 | $645K | |
| 2022 | 77,708 | $513K | |
| 2023 | 70,308 | $504K | |
| 2024incomplete | 54,183 | $419K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| Z1034 | 22% | 15,960 | 11,106 | $989K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 56,284 | 48,711 | $641K |
| Z1032 | 9.1% | 2,546 | 2,546 | $405K | |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 8.6% | 6,047 | 5,999 | $382K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 8.5% | 39,386 | 35,760 | $379K |
| J3490 | Unclassified drugs | 5.4% | 12,244 | 10,838 | $240K |
| 59514 | 4.7% | 4,646 | 4,070 | $206K | |
| Z6500 | 4.0% | 1,423 | 1,423 | $178K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.7% | 4,920 | 4,366 | $166K |
| 59425 | 2.5% | 32,708 | 22,710 | $112K | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | 1.9% | 60,644 | 40,150 | $86K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 1.8% | 283 | 275 | $79K |
69 more codes
| 81025 | 1.6% | 118,067 | $72K | |
| Z6400 | 1.6% | 3,735 | $72K | |
| 90715 | 1.0% | 6,396 | $46K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 3,400 | $44K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 4,732 | $38K |
| Z6410 | <1% | 3,241 | $25K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 5,262 | $25K |
| H1000 | Prenatal care, at-risk assessment | <1% | 7,171 | $24K |
| H2000 | Comprehensive multidisciplinary evaluation | <1% | 3,032 | $22K |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 26,041 | $17K |
| 11981 | <1% | 198 | $16K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,083 | $16K |
| 59430 | <1% | 9,151 | $16K | |
| 57454 | <1% | 2,024 | $14K | |
| A4267 | Contraceptive supply, condom, male, each | <1% | 817 | $12K |
| 99385 | <1% | 1,079 | $12K | |
| Z1038 | <1% | 310 | $12K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 7,070 | $9K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 19,831 | $8K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,725 | $7K |
| H1002 | Prenatal care, at risk enhanced service; care coordination | <1% | 3,169 | $7K |
| 51784 | <1% | 1,906 | $6K | |
| 58300 | <1% | 505 | $4K | |
| 90656 | <1% | 574 | $4K | |
| 91122 | <1% | 938 | $4K | |
| 51701 | <1% | 189 | $4K | |
| 99401 | <1% | 4,599 | $4K | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 1,225 | $3K |
| 81002 | <1% | 9,797 | $3K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 34 | $3K |
| 90674 | <1% | 318 | $2K | |
| 90686 | <1% | 419 | $2K | |
| 99386 | <1% | 167 | $2K | |
| 59025 | Fetal non-stress test | <1% | 1,749 | $1K |
| 97750 | <1% | 904 | $1K | |
| Z6406 | <1% | 125 | $1K | |
| 90688 | <1% | 185 | $1K | |
| 97803 | <1% | 3,422 | $883.19 | |
| Z6204 | <1% | 110 | $859.24 | |
| Z6304 | <1% | 105 | $807.77 | |
| 58301 | <1% | 176 | $774.76 | |
| 96156 | <1% | 3,900 | $650.50 | |
| J2790 | Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) | <1% | 15 | $582.19 |
| 97032 | <1% | 933 | $519.52 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 62 | $499.77 |
| 96151 | <1% | 1,102 | $482.37 | |
| 87481 | <1% | 358 | $383.88 | |
| 11976 | <1% | 74 | $350.01 | |
| 58100 | <1% | 419 | $304.47 | |
| 97802 | <1% | 579 | $278.07 | |
| 87511 | <1% | 357 | $218.04 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 357 | $170.28 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 357 | $168.10 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 390 | $155.45 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 390 | $154.95 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 144 | $114.48 |
| S9452 | Nutrition classes, non-physician provider, per session | <1% | 1,149 | $88.33 |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 448 | $45.67 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 53 | $36.80 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 106 | $22.21 |
| S0197 | Prenatal vitamins, 30-day supply | <1% | 25 | $21.60 |
| 96150 | 0% | 185 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 27 | $0.00 |
| 86580 | 0% | 19 | $0.00 | |
| 64566 | 0% | 96 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 20 | $0.00 |
| T1024 | Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter | 0% | 32 | $0.00 |
| 96152 | 0% | 133 | $0.00 | |
| 21034 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEE, FENGLALY (PRESIDENT)